Europe

Oct 01, 2015
Nick Hicks looks at the challenges of devising a patient advocacy strategy amid the complex political, cultural and regulatory landscape of Russia and CIS.
Aug 27, 2015
France's bid to regain its influence reveals how far Europe is from fully achieving regulatory convergence, writes Reflector.
Aug 17, 2015
By Pharmaceutical Executive Editors
The move towards centralization and harmonization means that the regulatory and pharmacovigilance functions can no longer work independently, writes Markus Dehnhardt, Ph.D.
Jul 16, 2015
There are evident challenges for pharma in the ongoing Greek crisis. But, writes Reflector, there are some less evident challenges which may, over time, prove to be more difficult for the industry to cope with.
Jul 09, 2015
All indications are that the July 2016 deadline for transition from Europe's eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) to the new IDMP is not achievable. Sophie Daniels reports.
Jun 21, 2015
With Ireland’s signing of a vaccine procurement agreement this month, the EU’s move toward joint action on medicine acquisition is gathering pace, writes Reflector.
May 20, 2015
NICE's proposed Innovation Office emerges with a new name. Leela Barham reports.
May 19, 2015
Reflector looks at the revitalized European Union directive on patients’ rights in cross-border healthcare.
May 11, 2015
EUnetHTA has developed guidelines to help “set a general framework for EUnetHTA on how to conduct economic evaluations”, arguably HTA's most controversial element. Leela Barham reports.
native1_300x100
lorem ipsum